Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-25-000541
Filing Date
2025-04-22
Accepted
2025-04-22 17:15:11
Documents
7
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 e664292_def14a-immunic.htm DEF 14A 790277
2 GRAPHIC image_001.jpg GRAPHIC 6563
3 GRAPHIC image_003.jpg GRAPHIC 788
4 GRAPHIC image_005.jpg GRAPHIC 746
5 GRAPHIC image_006.jpg GRAPHIC 631
6 GRAPHIC image_007.jpg GRAPHIC 48565
7 GRAPHIC image_008.jpg GRAPHIC 64826
  Complete submission text file 0001193805-25-000541.txt   960441
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36201 | Film No.: 25858555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)